← Evidence map

ArticleDermatology and therapy2026

Dupilumab Improves Health-Related Quality of Life in Omalizumab-Naïve Patients with Chronic Spontaneous Urticaria.

Ana M Giménez-Arnau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 41326897